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ARTICLE
Spt6 is a maintenance factor for centromeric
CENP-A
Georg O. M. Bobkov1,2, Anming Huang3,9, Sebastiaan J. W. van den Berg4,5,9, Sreyoshi Mitra4,5,9,
Eduard Anselm1, Vasiliki Lazou1, Sarah Schunter6, Regina Feederle 7, Axel Imhof 8, Alexandra Lusser 3,
Lars E. T. Jansen 5 & Patrick Heun 1✉
Replication and transcription of genomic DNA requires partial disassembly of nucleosomes to
allow progression of polymerases. This presents both an opportunity to remodel the
underlying chromatin and a danger of losing epigenetic information. Centromeric transcrip-
tion is required for stable incorporation of the centromere-specific histone dCENP-A in M/G1
phase, which depends on the eviction of previously deposited H3/H3.3-placeholder
nucleosomes. Here we demonstrate that the histone chaperone and transcription elongation
factor Spt6 spatially and temporarily coincides with centromeric transcription and prevents
the loss of old CENP-A nucleosomes in both Drosophila and human cells. Spt6 binds directly
to dCENP-A and dCENP-A mutants carrying phosphomimetic residues alleviate this asso-
ciation. Retention of phosphomimetic dCENP-A mutants is reduced relative to wildtype, while
non-phosphorylatable dCENP-A retention is increased and accumulates at the centromere.
We conclude that Spt6 acts as a conserved CENP-A maintenance factor that ensures long-
term stability of epigenetic centromere identity during transcription-mediated chromatin
remodeling.
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Centromeres constitute a platform for the assembly of thekinetochore during mitosis and mediate the attachment ofchromosomes to the mitotic spindle for proper segrega-
tion of chromosomes. The position of the centromere is mostly
determined epigenetically through the incorporation of the
H3-variant CENP-A (CID/dCENP-A in Drosophila)1,2. Cen-
tromeric chromatin is composed of interspersed arrays of CENP-
A and canonical histone H3 nucleosomes3. While canonical H3 is
replenished during DNA replication in S-phase4, loading of
CENP-A in Drosophila and humans takes place in a replication-
independent manner from late mitosis to G15–9. This process
requires the exchange or removal of so-called placeholder
nucleosomes containing H3 and H3.3, which have been posi-
tioned on centromeric DNA-sequences during the previous
S-phase10,11.
As expected for an epigenetic mark, centromeric CENP-A
nucleosomes are remarkably stable and can be propagated not
only over multiple cell divisions but also across generations.
Indeed, epitope-tag labeling of dCENP-A revealed that once fully
incorporated, CENP-A turnover in healthy proliferating cells is
almost exclusively restricted to replicative dilution12,13. Some of
this stability is conferred to CENP-A by other centromere factors
that act on the intact DNA-bound nucleosome itself. While
CENP-C reshapes and clamps down the CENP-A nucleosome,
CENP-N helps fastening CENP-A to the underlying DNA14,15.
The remarkable stability of CENP-A is further demonstrated by
the fact that CENP-A nucleosomes that are assembled in mouse
oocytes before birth, persist in the chromatin of prophase I-
arrested cells for over a year and are sufficient for genome
transmission to embryos through the entire fertile lifespan of the
mouse16.
In actively dividing cells, however, chromatin is a highly
dynamic structure. Cellular processes that require direct DNA
contact like DNA replication or transcription induce large-scale
chromatin remodeling events to allow the progression of DNA-
and RNA- polymerases. This involves partial or full disassembly
of nucleosomes17, which challenges the stable transmission of
epigenetic marks encoded in histone variants or histone tail
modifications. Accordingly, mechanisms need to be in place to
ensure faithful transmission of epigenetic signals during replica-
tion and transcription.
CENP-A is the key epigenetic mark for the centromere and has
been shown to be maintained during the replication of cen-
tromeric DNA5,6,12. Recent work identified the MCM2-7 repli-
cative helicase to recycle previously deposited H3/H4, H3.3/H4,
and CENP-A/H4 tetramers together with other chaperones dur-
ing S-phase to ensure the transfer of parental nucleosomes to
freshly replicated DNA18–21.
Centromeres are also sites of active transcription, as revealed
by the centromeric presence of RNA Polymerase II (RNAPII),
centromeric RNA transcripts and transcription-associated his-
tone modifications in various organisms including yeast, flies and
humans9,22–31. Centromeric transcription is important for cen-
tromere function32, and it has been proposed that transcription-
mediated chromatin remodeling is required for CENP-A
loading9,22,33. However, it is currently unclear how old CENP-
A nucleosomes survive the passage of the elongating RNAPII.
Active removal of CENP-A through induced upregulation of
transcription at the centromere has been observed in a variety of
organism including on plasmids in budding yeast, on artificial
chromosomes in human cells34,35 and as a consequence of gen-
otoxic stress in senescent murine cells36.
To counteract the transcription-coupled eviction of nucleo-
somes and to ensure genome integrity, chromatin needs to be
rapidly re-established in the wake of the DNA- and RNA poly-
merase. During DNA replication, this is achieved through
deposition of canonical histones, whereas nucleosome gaps cre-
ated by genomic transcription are filled through the replication-
independent incorporation of H3.34,37 as well as the recycling of
displaced old histones. Disassembly of nucleosomes in front of a
progressing RNAPII involves the histone chaperone Facilitates
Chromatin Transcription (FACT)17,18. FACT also acts to reas-
semble nucleosomes behind RNAPII together with the tran-
scription elongation factor and histone chaperone Spt638. Spt6
can interact with histones, assembles them into nucleosomes39,
and is able to increase the elongation rate of RNAPII both in vitro
and in vivo40,41.
While a role for FACT at the centromere and its importance
for CENP-A deposition has already been demonstrated in
numerous organisms22,33,42,43, little is known about a cen-
tromeric function of Spt6. Interestingly, Spt6 was detected in a
CENP-A pull-down and mass-spectrometry experiment both in
budding yeast and in flies44,45. Budding yeast mutants of Spt6
further show segregation defects for a chromosome fragment46,
whereas mutants in Schizosaccharomyces pombe exhibit genome-
wide CENP-A misincorporation22. Importantly, Spt6 prevents
transcription-coupled loss of nucleosomes in gene bodies by
reincorporating H3/H4 tetramers displaced during transcription.
Consequently, Spt6 preserves the epigenetic information encoded
in histone tail posttranslational modifications (PTMs) of recycled
nucleosomes38,47. Spt6 further stabilizes nucleosomes by remov-
ing transcription-induced histone acetylation through a self-
enforcing protein network comprising Spt6, the histone deace-
tylase Rpd3 and the H3K36 methyl-transferase Set248,49. Con-
sistent with a major role of Spt6 in the restoration of
transcriptionally perturbed chromatin in the wake of a progres-
sing RNAPII, cryptic promoters are activated within transcription
units in mutants for Spt650,51.
Here we demonstrate that transcription at the centromere,
while being important for loading of new CENP-A, simulta-
neously poses a threat to the maintenance of ancestral CENP-A
nucleosomes. We further show that long-term stability of the
centromeric mark is achieved through effective recycling of
expelled dCENP-A by Spt6 in both Drosophila and in
human cells.
Results
Spt6 is present at mitotic and G1 centromeres. To identify novel
factors associated with Drosophila centromeres we previously
affinity-purified GFP-tagged dCENP-A containing nucleosomes
and combined it with mass-spectroscopy analysis. Among the
proteins enriched in dCENP-A containing chromatin was the
transcription elongation factor and histone chaperone Spt645.
To verify the identification of Spt6 as a centromere-associated
protein, we investigated its cellular localization using fluorescence
microscopy. Both endogenous Spt6 as well as a GFP-tagged
transgenic construct were detected at mitotic centromeres (Fig. 1a,
b; upper panel) and colocalised with dCENP-A and RNAPII
(Supplementary Fig. 1a). In interphase, Spt6 most prominently
stained non-centromeric, transcriptionally active areas, whereas
the centromere surrounding heterochromatin was largely devoid
of any signal. In a subpopulation of interphase cells, additional
Spt6 foci that overlapped with centromere counterstaining were
visible (Fig. 1a, b; lower panel). To characterize the localization of
Spt6 with respect to various cell cycle stages in greater detail, we
investigated cells that simultaneously expressed dCENP-A-
mCherry and Spt6-GFP by live-cell microscopy. In late G2 cells
just prior to the entry into mitosis, Spt6-GFP was not detectable
at centromeres (Fig. 1c and Supplementary Fig. 1b). While high
levels of nucleo-cytoplasmic Spt6-GFP during mitosis interfered
with its precise localization in live-cell imaging, Spt6-GFP
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appeared at centromeres within minutes of entering the
subsequent G1 phase (Fig. 1c) and remained there for a period
of 3–6 h (Supplementary Fig. 1b). Analysis of fixed S-phase cells
labeled through 5-ethynyl-2′-deoxyuridine EdU incorporation
(click-IT®) revealed very little to no centromeric Spt6 (Fig. 1d, e),
whereas investigation of midbody containing cells confirmed its
presence at early G1 centromeres (Supplementary Fig. 1c).
This cell cycle-dependent localization pattern mirrors the
previous mapping of centromeric RNAPII and centromere-
associated transcripts to mitotic and G1 centromeres9. Indeed,
combining Spt6 immunostaining with pulse labeling of nascent
RNA using the Click-It® technology allowed the simultaneous
detection of Spt6 together with centromere-associated transcripts
at the same interphase centromeres (Fig. 1f). Taken together,
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Fig. 1 Spt6 localizes to centromeres in mitosis and G1. a Single optical section of fixed metaphase (upper panel) and interphase (lower panel) cells
immunostained for endogenous Spt6 and dCENP-A. N= 3 independent experiments. b Single optical section of fixed metaphase (upper panel) and
interphase (lower panel) S2 cells expressing Spt6-GFP. N= 3 independent experiments. dCENP-A immunodetection served as a marker of centromeres.
c Analysis of the localization of GFP-tagged Spt6 using life imaging of cells 1 h before (late G2; n= 23 cells) and 1 h after (G1; n= 39 cells) anaphase onset.
Movies were taken in a cumulative way. Error bars= standard error of the mean; SEM. Quantification was based on images shown in Supplementary Fig.1a.
d Quantification of Spt6 localization in fixed EdU incorporating S-phase cells exemplified in (e). N= 3 independent experiments; n= 93 S-phase cells. Data
are represented as mean+ standard deviation; SD. e Single optical section of fixed S-phase cell immunostained for Spt6 and dCENP-A. Incorporation of
EdU served as a marker for S-phase. Boxes indicate the 3× enlarged inset. Scale bar represents 3 µm. f G1 phase S2 cell with nascent RNA production
labeled by click-iT EU and immunostained for Spt6. N= 3 independent experiments. Yellow arrow heads point to centromeric Spt6. Boxes indicate the 3×
enlarged inset. Scale bars represent 3 µm. Source data are provided as a Source Data file.
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centromeric association of Spt6 is cell cycle regulated and largely
restricted to centromeres of mitotic and G1 cells.
RNAi-mediated depletion of Spt6 causes mitotic defects. Next,
we decided to investigate the effects of Spt6 depletion via RNA
interference (RNAi) in Drosophila S2 cells (Supplementary
Fig. 2a). Interestingly, we observed a strong increase in mitotic
defects in Spt6-depleted cells to levels comparable to prolonged
RNAi depletion of the highly stable dCENP-A protein (Supple-
mentary Fig. 2b). While mitotic defects in Spt6 RNAi were
dominated by lagging chromosomes, dCENP-A depletion mainly
resulted in chromosome congression defects (Supplementary
Fig. 2c). This suggests a potential impact on centromere func-
tionality, which is consistent with previously reported mis-
segregation of a chromosome fragment in a budding yeast Spt6
mutant46. However, during the course of the RNAi experiment,
we noticed an apparent decrease of mitotic cells in samples
treated for more than 2 days with dsRNAs targeting Spt6 (Sup-
plementary Fig. 2d). Measurement of cell numbers in RNAi-
treated cultures confirmed that depletion of Spt6 leads to a cell
cycle block whereas control cells depleted for the white protein
were unaffected (Supplementary Fig. 2e). Subsequent
fluorescence-activated cell sorting (FACS) analysis revealed that
the cell cycle arrest of Spt6-depleted cells was not specific and
instead occurred across all cell cycle stages (Supplementary
Fig. 2f).
Spt6 depletion by deGradFP reduced dCENP-A at centromeres.
Spt6 localization to centromeres in mitosis and G1 matches the
time window where new dCENP-A is incorporated into Droso-
phila centromeres6–9. Spt6 has further been shown to increase the
elongation rate of RNAPII40,41 and recycle previously deposited
nucleosomes during genomic transcription47. CENP-A loading
requires the exchange of placeholder nucleosomes10,11, which has
been proposed to be mediated by transcription-induced chro-
matin remodeling9,22,33. We therefore hypothesized that Spt6
might also play a role during centromeric transcription and the
loading or maintenance of dCENP-A.
As loading of dCENP-A is coupled to progression through the
cell cycle, the depletion of Spt6 via RNAi is not suitable to assess
potential changes in dCENP-A deposition, especially as the cell
cycle block already occurs with Spt6 levels only being reduced to
roughly 50% (Supplementary Fig. 2a). To overcome this problem,
we used the CRISPR/Cas9 technique to GFP-tag endogenous Spt6
between the second and third exon, inspired by the fully
functional GFP-Spt6 protein produced in a GFP-TRAP study
(Supplementary Fig. 3a)52 and combined it with a system
targeting GFP for degradation, called deGradFP53. Western blot
analysis confirmed that the GFP-fusion protein is the only form
of Spt6 present in our stable S2 cell line (Clone C4,
Supplementary Fig. 3b). Rapid, inducible degradation of GFP-
Spt6 was achieved by adapting the deGradFP system to respond
to the small molecule Shield154. Accordingly, we modified the
original F-box-construct through addition of a degron domain
(FKBP-L106P) that results in constant degradation of the fusion
protein. Addition of Shield1 stabilizes FKBP-F-box-GFP Binding
Protein, which then initiates the degradation of GFP-Spt6
(Fig. 2a). Indeed, we found that Shield1 induced rapid
degradation of Spt6 within 12–24 h as judged by IF of fixed cells
and western blot of total protein extracts (Fig. 2b, c). Interest-
ingly, Shield1 treatment for 21 h (<one generation time of 24 h)
led to a reduction of total dCENP-A at centromeres in Spt6-
depleted cells (Fig. 2c, d), suggesting either impaired loading of
new dCENP-A or increased loss of old dCENP-A.
Spt6 prevents transcription-coupled loss of old dCENP-A. To
distinguish between a defect in loading versus impaired main-
tenance of dCENP-A, we established the Recombination Induced
Tag Exchange (RITE)-technique55 in Drosophila S2 cells. This
technique allows simultaneous tracking of both new (MYC-tag-
ged) and old proteins (V5-tagged) via a Cre recombinase medi-
ated epitope-tag switch (Fig. 3a). Cells treated with Cre
recombinase stop transcription of the old and simultaneously
start transcription of the new tagged construct. dCENP-A
dynamics were assessed after a 21 h treatment with Cre recom-
binase in the presence or absence of GFP-Spt6 (Fig. 3b). We
found that levels of newly loaded dCENP-AMYC were not sig-
nificantly altered between both treatment conditions, although
they showed a tendency toward increased loading in Spt6-
depleted cells (Fig. 3c, e). In contrast, old dCENP-AV5 was sig-
nificantly depleted from centromeres in cells where Spt6 was
degraded (Fig. 3d, e).
Interestingly, the loss of old dCENP-AV5 was more pro-
nounced than the reduction observed for total dCENP-A levels in
Spt6-depleted cells (58% vs. 17% reduction; compare Figs. 3d and
2d), suggesting a partial compensation by increased incorporation
of new dCENP-A. However, the RITE system did not reveal a
significant increase in new CENP-AMYC, likely because not
enough new protein was produced during the course of the
experiment to fully compensate for the loss of old dCENP-AV5
(Supplementary Fig. 3c). To test this hypothesis, we combined
Spt6 degradation with a previously established tamoxifen-
inducible HA-tagged dCENP-A (TI-dCENP-AHA) loading sys-
tem9. In this system, TI-dCENP-AHA is constitutively produced
but cannot participate in dCENP-A loading, as it is sequestered
away in the cytoplasm due to an interaction with Hsp90. Only
upon treatment with 4-hydroxytamoxifen (4OHT) is TI-dCENP-
AHA released and a large pool of preproduced new dCENP-A
proteins becomes instantaneously available for incorporation into
centromeric chromatin. Indeed, when combined with simulta-
neous depletion of Spt6 using our inducible deGradFP system
(Fig. 3f), we observed a clear increase in incorporation of new
dCENP-A compared with cells with wild-type levels of Spt6
(Fig. 3g, h). Moreover, the presence of endogenous dCENP-A
combined with additional TI-dCENP-AHA completely equalized
total dCENP-A levels between cells with and without Spt6
depletion, in contrast to the reduction previously observed
following Spt6 degradation (compare Figs. 2d and 3i). In support
of this interpretation, western blotting of nuclear extracts for
dCENP-A revealed that overall protein levels of the transgenic
dCENP-AV5 constructs in the RITE system are much lower than
TI-dCENP-AHA provided by the tamoxifen system (Supplemen-
tary Fig 3c, d). In line with our microscopy analysis, we also
observed a reduction in total endogenous dCENP-A levels upon
Spt6 (Fig. 2d). However, it should be noted that western blots are
not well suited to reflect the specific centromeric contribution of
CENP-A, as the majority of CENP-A has been found to reside in
non-centromeric chromatin (up to 66% in human cells56).
Recombinant Spt6199–338 binds dCENP-A and H3 directly.
Intriguingly, the specific loss of previously deposited dCENP-A
during the loading process of new dCENP-A in Spt6-depleted
cells suggests that Spt6 binds and reincorporates not only H347,
but also dCENP-A/H4 tetramers. An association of Spt6 with
dCENP-A can be expected from our previously published mass
spectroscopy of dCENP-A interactors45. Although the exact
binding interface is not known, binding of basic histones to the
unstructured highly acidic N-terminus of Spt6 (Fig. 4a, b) has
been demonstrated in Saccharomyces cerevisiae39. To test whether
the interaction between Spt6 and dCENP-A is direct, we
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expressed a N-terminal fragment of Drosophila Spt6 (residues
199–338), which encompasses the histone-binding domain of
yeast Spt6 (residues 239–314) based on amino acid sequence
alignments (Fig. 4b). Recombinant Spt6 (199–338) was expressed
and purified from bacteria and pull-down experiments revealed
direct binding of Spt6 to both recombinant H3/H4 and dCENP-
A-ΔNterm (101–255)/H4 tetramers, but not to the epitope tag
alone control (6his-smt3) (Fig. 4c). Less H4 was pulled down than
H3 or dCENP-A-ΔNterm indicating a potential binding of Spt6
to H3 or dCENP-A alone. As we could only produce soluble
dCENP-A without its N-terminal tail in bacteria, we further
confirmed that endogenous Spt6 is able to co-immunoprecipitate
(IP) with full length dCENP-AFLAG using Drosophila S2 cell
extracts (Fig. 4d).
Mutating dCENP-A phosphoresidues affect Spt6 binding. It
has been shown that upregulated centromeric transcription in
stressed and senescent murine cells can induce removal of CENP-
A from centromeres36. This was dependent on the DNA damage
response effector Ataxia-telangiectasia-mutated kinase and a
phosphorylatable S30 residue on CENP-A, suggesting that
phosphorylation events act in conjunction with transcription to
remove centromeric CENP-A. As Spt6 prevents transcription-
coupled loss of nucleosomes in gene bodies47, this prompted us to
generate cell lines that express Flag-tagged dCENP-A bearing
mutations at three previously reported phosphorylation sites of its
N-terminal tail (S20, S75, and S7757). The respective serines were
mutated to either phosphomimetic aspartates or to non-
phosphorylatable alanines. In line with a potential negative
effect on dCENP-A retention through phosphorylation, a single
(S77D) or triple (S20/S75/S77D) substitution to aspartate almost
completely abolished co-immunoprecipitation of dCENP-A with
Spt6 (Fig. 4d). In contrast, the serine-to-alanine mutation dis-
played similar (S77A) or modestly increased (S20/S75/S77A)
association with Spt6 as compared with wild-type dCENP-A. To
test whether Spt6 shows different interaction specificity for H3
and dCENP-A, we exposed the co-IPs to high salt (750 mM)
washes. While high salt treatment abolished the association of
Spt6 with canonical H3, a clearly detectable population of wild-
type dCENP-AFLAG or the non-phosphorylatable triple alanine
dCENP-A mutant (S20/S75/S77A) remained bound to Spt6
(Fig. 4e).
Phosphorylation affects retention of centromeric dCENP-A.
Next, we tested whether the altered interactions between Spt6 and
dCENP-A-mutants also correlate with changed centromeric levels
of dCENP-A. We quantified the steady-state level of SNAP-
tagged-dCENP-A at centromeres in stably transfected S2 cells
that express wild-type or mutant constructs (S77D or S77A;
Fig. 5a–d). Consistent with the co-IP results, we find that cen-
tromeric dCENP-A-S77D intensities were strongly decreased (≈3-
fold vs. WT; Fig. 5a, b). Surprisingly, we also observed a sig-
nificantly higher abundance of dCENP-A-S77A in centromeres as
compared with wild-type dCENP-A (≈2.8-fold, Fig. 5c, d). An
accumulation of dCENP-A-S77A is unexpected, if endogenous
CENP-A is only subjected to replicative dilution12 but otherwise
100% stable.
We therefore investigated retention of dCENP-A in more detail
using a SNAP-based fluorescent pulse-chase approach to follow
the decline of old wildtype, S77A or S77D dCENP-A over 2 cell
generations (48 h) at individual mitotic centromeres (Fig. 5e, f, g
Supplementary Fig. 4). Interestingly, we uncovered a low level of
wildtype dCENP-A loss after two cycles in addition to replicative
dilution (20% instead of the expected 25% of the original
c
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intensity), in agreement with recent findings that challenge the
high intrinsic stability of CENP-A13. In contrast, the retained
levels of the S77A mutant are closer to perfect inheritance (23%),
while, as expected, the remaining amounts of the phosphomi-
metic mutant are much lower (13%). This difference is further
revealed by calculating the half life and decay rate constant for
each mutant after 48 h (Fig. 5g), providing an explanation for
how the S77A mutant can accumulate relative to wild-type
dCENP-A.
Depletion of human SPT6 interferes with CENP-A main-
tenance. To determine whether our observations are general-
izable across species, we depleted the highly conserved SPT6
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protein in human HeLa cells. We measured the rate of CENP-A
retention across the cell cycle using SNAP-based fluorescent pulse
labeling that specifically tracks ancestral chromatin-bound
CENP-A12,58. As in Drosophila S2 cells, strong depletion of
SPT6 results in secondary phenotypes including a cell cycle arrest
which indirectly interferes with CENP-A loading by blocking
passage through M- and G1 phase. To prevent this, we partially
depleted SPT6 (Fig. 6b) using specific siRNAs and controlled the
cell cycle speed by a Thymidine arrest and release protocol to
allow SPT6-depleted cells to complete a cell cycle (Fig. 6a). We
ensured cells reached G1 phase based on the lack of Cyclin B
staining (Supplemental Fig. 5a, b). Under these conditions we
observe a reproducible 20% reduction in CENP-A maintenance in
a single cell cycle. Two different siRNAs resulted in similar
effects, indicating CENP-A loss is due to on target SPT6 depletion
(Fig. 6b, c). We expected this effect to be modest as expression of
SPT6 is by necessity hypomorphic. CENP-C, a previously iden-
tified CENP-A maintenance factor, was used as control14.
Although further investigation will be required to exclude the
possibility of unspecific effects on CENP-A stability, SPT6
depletion did not affect CENP-C levels indicating that the effect
of SPT6 depletion on CENP-A is not an indirect consequence of
CENP-C loss (Fig. 6b, right panel). Unlike what has been
observed for fission yeast22, we did not detect CENP-A mis-
localisation after Spt6 depletion in either Drosophila or human
cells. In summary, these data support a conserved role for SPT6
in CENP-A maintenance in human cells.
Discussion
The CENP-A nucleosome is considered to be the key epigenetic
mark for centromere identity in most organisms. Accordingly,
CENP-A and epigenetic marks in general should meet three
requirements: (1) Template its own deposition, (2) be replenished
in a cell cycle-controlled manner to counteract dilution by half in
each S-phase and (3) be stably transmitted to the next cell
generation59.
New dCENP-A can be targeted to sites of previous CENP-A
deposition by its chaperone CAL1, which is recruited to cen-
tromeres by dCENP-C60,61. Loading of new CENP-A is restricted
to mitosis and G15–8 and serves primarily to replenish CENP-A
containing nucleosomes that became diluted by half during the
preceding S-phase. During DNA replication the MCM2-7 repli-
cative helicase along with other histone chaperones like HJURP,
are instrumental for the stable transmission of parental CENP-A
during S-phase19–21.
We have recently shown in Drosophila S2 cells that tran-
scription at the centromere is required for stable nucleosome
incorporation of new dCENP-A9. This finding could be explained
by a model in which transcription-mediated chromatin remo-
deling is re-purposed to evict placeholder H3 nucleosomes to
make room for deposition of new dCENP-A. However, the
induction of nucleosome eviction during CENP-A loading also
bears the danger of losing previously incorporated CENP-A
(Supplementary Fig. 6). Here we report the identification of the
transcription elongation factor and histone chaperone Spt6 as a
new CENP-A maintenance factor, which safeguards previously
deposited CENP-A during centromeric transcription (Fig. 7).
We find that Drosophila Spt6 localizes to centromeres during
mitosis and G1 (Fig. 1 and Supplementary Fig. 1), coinciding with
the time window when transcription and dCENP-A loading
occurs6–9. The SH2 domain enables Spt6 to interact directly with
RNAPII48,62,63 and it is therefore likely that recruitment of Spt6
to centromeres is a direct consequence of centromeric tran-
scription. Because Spt6 prevents transcription-coupled loss of
posttranslationally modified nucleosomes in gene bodies38,47, we
tested whether Spt6 might act to maintain dCENP-A at the
centromere. Indeed, when we depleted Spt6 in Drosophila or
human cells, we observed the specific loss of old CENP-A after
passage through mitosis into G1 phase (Figs. 3 and 6). This
observation suggests that ongoing transcription evicts nucleo-
somes at centromeres and that Spt6 serves a conserved role to
recycle CENP-A/H4 tetramers expelled by closely spaced poly-
merase complexes17. A key point of this model is the
transcription-mediated creation of nucleosomal gaps as a pre-
requisite for full incorporation of new dCENP-A (Fig. 79). Con-
sequently, the additional loss of nucleosomes in Spt6-depleted
cells should create more opportunities to load new dCENP-A.
Indeed, when we used an experimental system that provides
elevated levels of transgenic, ready-made dCENP-A (TI-dCENP-
AHA), we observed a clear increase in loading (Supplementary
Fig. 3d, Fig. 3g, h). This is further supported by the fact that the
loss of total centromeric dCENP-A in Spt6-depleted cells is
completely compensated under these conditions (compare
Figs. 2d and 3i).
We currently do not know if the mitotic defects observed upon
Spt6 depletion by RNAi are a direct or indirect consequence of
Spt6 removal (Supplementary Fig. 2b–d). As cells can tolerate
very low CENP-A levels at the centromere down to 10%64, the 2-
day depletion of Spt6 likely leaves sufficient dCENP-A for cen-
tromere function. Despite this, chromosome segregation might be
compromised due to the specific loss of old nucleosomes with
specific PTMs. PTMs relevant for centromere function have been
identified on CENP-A and shown to affect CENP-A stability and
correct mitotic progression65,66. Moreover, methylation of lysine
20 on the associated H4 plays an essential role for kinetochore
formation67. Likewise, in addition to CENP-A nucleosomes,
centromeres contain canonical H3 nucleosomes with a specific set
of posttranslational modifications that might need to be
retained24,31. We therefore postulate that Spt6 should be able to
distinguish between placeholder nucleosomes that need to be
removed and epigenetically marked nucleosomes that should be
kept. As previously demonstrated for H3/H4 in budding yeast39,
Fig. 3 Parental dCENP-A is lost in Spt6-depleted cells. a Scheme displaying the RITE system used to distinguish old and new protein simultaneously
(adapted from Verzijlbergen et al.55). b Experimental setup used in (c–e). Quantification of the centromeric incorporation of new dCENP-AMYC (c) or
remaining levels of old dCENP-AV5 (d) at centromeres under Spt6 depletion conditions (58% reduction). N= 3 independent experiments; nWT= 54,
ndepl = 107 cells. Statistical significance: quadruple dots P < 0.0001; n.s. not significant (unpaired, two-tailed Mann–Whitney test). e Maximum intensity
projection of representative cells measured in c, d. Cells treated with Cre recombinase (upper panel) or Cre recombinase plus Shield1 (lower panel) are
shown. Boxes indicate the 4× enlarged inset. Scale bar represents 3 µm. f Experimental setup used in (g–i). g Quantification of new centromeric dCENP-
AHA in fixed cells following 4OHT mediated release of TI-dCENP-AHA and depletion of Spt6 through Shield1 treatment. N= 3 independent experiments,
nWT= 30, ndepl= 47 cells. Data are represented as scatter plots with mean and 95% CI. h Maximum intensity projection of representative cells measured
in g, i. 4OHT treated (upper panel) and 4OHT plus Shield1 treated cells (lower panel) are shown. Boxes indicate the 4× enlarged inset. Scale bar represents
3 µm. i Quantification of total centromeric dCENP-A in fixed cells following 4OHT mediated release of TI-dCENP-AHA and depletion of Spt6 through Shield1
treatment. N= 3 independent experiments, nWT= 30, ndepl= 52 cells. All data plots are represented as scatter plots with mean and 95% CI. Statistical
significance: double dots P= 0.0025; n.s. not significant (unpaired, two-tailed Mann–Whitney test). Source data are provided as a Source Data file.
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we observe direct binding of a bacterially expressed N-terminal
fragment of Spt6 (199–338) with both H3/H4 and dCENP-
AΔNT/H4 tetramers (Fig. 4b). In addition, full length dCENP-
AFLAG and H3 co-IP with endogenous Spt6 from S2 cell extracts
with comparable efficiency (Fig. 4e).
Interestingly, CENP-A is phosphorylated in various organisms
including flies and humans57,68,69 and phosphorylation events
have been linked to transcription-induced loss of centromeric
CENP-A nucleosomes in mouse cells36. To test whether phos-
phorylation of dCENP-A affects its maintenance, we mutated
three previously identified phosphorylation sites in the N-
terminal tail of dCENP-A (S20, S75 and S7757). Indeed, we
found that dCENP-A mutants carrying the phosphomimetic
residue aspartate showed significantly reduced binding to Spt6,
while the opposite was observed for the respective non-
phosphorylatable alanine mutants (Fig. 4d). Furthermore,
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Source Data file.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-16695-7
8 NATURE COMMUNICATIONS |         (2020) 11:2919 | https://doi.org/10.1038/s41467-020-16695-7 | www.nature.com/naturecommunications
WT
S77A
S77D
Repl. dil.
%
 in
te
ns
ity
 p
er
 c
en
tro
m
er
e
DNA
dCENP-A
dCENP-A: WT S77D
WT S77D
%
 c
en
 in
te
ns
ity
%
 c
en
 in
te
ns
ity
a b
dc dCENP-A: WT S77A
e
g
Quant.
Mitotic
chromosomes
f
DNA
dCENP-A
dCENP-A: WT
0
S77DS77A
13 16.3 0.043 ± 0.008
20 20.8 0.031 ± 0.004
23
25
Half life
(h)
Signal
(%)
24 0.029
Decay const. k
(h–1)
50
100
3 μm
150
200
400
600
25
0
48 0 48 0 48 h
••••
••••
0
100
200
300
400
500
0
100
200
•
22.7 0.033 ± 0.006
0 20 40
0
25
50
75
100
h
%
 s
ig
na
l in
te
ns
ity
••••
S77AWT
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(± upper and lower 95% CI) were calculated using the one-phase-decay function of Prism 8.4.0. Source data are provided as a Source Data file.
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wild-type or non-phosphorylatable mutants of dCENP-A bound
robustly to Spt6 when exposed to high salt washes while canonical
H3 binding was abolished (Fig. 4e). This difference hints toward a
mechanism how Spt6 distinguishes between the two histone H3-
variants and allows selective retention of CENP-A, while place-
holder nucleosomes are exchanged. Consistent with the obser-
vations described above, a pulse-chase experiment to follow the
decline of old dCENP-A during cell division showed higher loss
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rate for the phosphomimetic dCENP-A construct. Interestingly,
dCENP-A wild-type displayed less than perfect inheritance after
two cell cycles (<25% expected for replicative dilution). In con-
trast S77A was on average more and S77D less stable than wild
type (Fig. 5f), likely accounting for the accumulation of the non-
phosphorylatable dCENP-A mutant at centromeres over time
(Fig. 5c).
Taken together, we propose that the transcription-mediated
eviction of centromeric nucleosomes affects both placeholder H3
and previously deposited CENP-A nucleosomes. However, loss of
the centromeric mark is prevented by specific recycling of CENP-
A through Spt6, potentially involving phospho-regulation of the
CENP-A/Spt6 interaction (Fig. 7). We conclude that Spt6 acts as
an important CENP-A maintenance factor and contributes to the
long-term stability of the epigenetic centromere mark.
Methods
Plasmid constructs. Spt6 was PCR’ed from genomic S2 cell cDNA and cloned into
the SpeI/EcoRV sites of a pMT-CID-GFP-hygro vector (primers dSpt6_F1,
dSpt6_R2) and a pIB-vector (Invitrogen; primers dSpt6_F1, dSpt6_R-AscI),
creating pMT-Spt6-GFP-hygro and pIB-resSpt6-stop. The
pMT_FKBP_L106P_Fbox_GFPbinder_hygro_opt plasmid was constructed for the
degradFP technique by cloning two gBlock DNA fragments (IDT) for the
FKBP_L106P degron (KpnI/SpeI) and the F-box-GFP binder (SpeI/XbaI) into the
pMT_V5_hygro. CID-HA-ERT2 (=TI-dCENP-AHA)9 is subcloned using KpnI/
AgeI into pMT_kana_opt. The pRITE_MT_CID_V5_puro_3myc_CD4 plasmid
used for RITE was constructed by combining several synthesized gBlock DNA
fragments (IDT) and a PCR-fragment containing the CD4 gene into the NotI/PmeI
site of a pMT-CID-V5 plasmid (for sequence details, see Supplementary Table 1).
The 1kup_resGFPSpt6_stop-plasmid was generated by inserting the PCR’ed
genomic region of Spt6 1 kb upstream fragment (primers 1kup_F_BstZ17I,
2kup_R_NheI) into the pIB-Spt6 vector using BstZ17I/NheI. A gBlock containing a
synthesized artificial GFP-exon (resGFPSpt6) between the 2nd and 3rd Spt6-exon
using HindIII and Eco47III. pET3a_ΔN_CENP-A101–225 is described70, pET22b H3
and pET22b H4 were a gift from Karolin Luger. The Spt6199-338 fragment was
produced as a gBlock (IDT) and used directly in ligation-independent cloning into
pET-His6-Sumo TEV (14S Addgene plasmid # 48291), a gift from Scott Gradia. To
generate dCENP-A-S77A or -S77D single mutant constructs, primers S77A_F and
S77A_R (or S77D_F and S77D_R) were used for site-directed mutagenesis on
pMT-SNAP-CENP-A57 as template. To generate dCENP-A-S20/75/77A and
CENP-A-S20/75/77D triple-mutant constructs, first a pMT-S20A (pMR-S20D)
single mutant construct was made with primers S20A_F and S20A_R (S20D_F &
S20D_R) as above, the resulting plasmid was used for site-directed mutagenesis of
S75 with primers S75A_R and S75A_R (S75D_F & S75D_R) followed by site-
directed mutagenesis of S77 with primers B75AM77A_F and S77A_R
(B75DM77D_F & B75DM77D_R). For primer and gBlock sequences see Supple-
mentary Table 1.
Cell culture and generation of cell lines. Drosophila S2 Schneider cells were
grown at 25 °C in Schneider’s Drosophila medium (SERVA) supplemented with
10% fetal calf serum and antibiotics (0.3 mg/ml penicillin, 0.3 mg/ml streptomy-
cin). Cells were transfected using the XtremeGENE HP transfection reagent
(Roche) or Effectene Transfection Reagent (QIAGEN), and stable lines were
selected with 100 μg/mL hygromycin B, 2 μg/ml puromycin or 1 mg/ml G418
(kanamycin derivative). Degradation of Spt6 was induced in the CRISPR generated
GFP-Spt6 cell line clone C4 stably expressing the FKBP-deGradFP construct by
treatment for 21 h with 4 μM Shield1 in 1% DMSO (D8418, SIGMA) final con-
centration in the cell medium. Clone C4 was stably transfected with the
pMT_dCENPA-HA-ERT2-hygro (TI-dCENP-AHA) construct or the pRI-
TE_MT_CID_V5_puro_3myc_CD4 plasmid. Clone C4 expressing cytoplasmic-
ankered TI-dCENP-AHA was exposed to 10 μM 4-hydroxy-tamoxifen (4OHT;
T176, Sigma) for the last hour of a 21-h Shield1 (#632189, Takara) or 1% DMSO
control treatment. Clone C4 expressing the RITE construct was induced for
recombination by direct addition of 1 μM Cre Recombinase (TAT-Cre, EG-1001,
Excellgen) to the cell medium for 21 h in the presence of Shield1 or absence (1%
DMSO control).
HeLa CENP-A-SNAP cells were grown at 37 °C, 5% CO2 in DMEM cell culture
media supplemented with 10% newborn calf serum, 2 mM glutamine, 1 mM
sodium pyruvate (SP), 100 U/ml penicillin, and 100 μg/ml streptomycin. The HeLa
monoclonal cell lines stably expressing CENP-A-SNAP were a gift from Don W.
Cleveland (UCSD) and is the same cell line used for many centromere studies in
human cells (clone#72)5.
RNAi. Exponentially growing S2 cells were incubated for 30′ in 1 ml serum-free
medium containing 20 µg of dsRNA before 3 ml of serum-containing medium were
added. Cells were harvested after 3 (white/Spt6) or 7 (dCENP-A) days. Primers
used for dsRNA synthesis: Spt6_F, Spt6_R, dWhite_F, dWhite_R,
RNAi in HeLa cells was performed in a 24-well format with 2.5 pmol of small
interfering RNAs final concentration (siRNAs) using Lipofectamine® RNAiMAX
Transfection Reagent (Invitrogen) according to the manufacturer’s instructions. All
siRNAs were obtained from Silencer® Select Pre-Designed & Validated siRNA (Life
Technologies): CENP-C (s2913), SPT6 (s13634, s13635). Neg9 depletion siRNA
target was used as a control (ctrl). Following RNAi, HeLa cells were synchronized
by addition of 2 mM thymidine to complete medium for 17 h. Cells were released
into G2 and through G1 by washing them twice in complete medium before
incubating them in complete media containing 24 µM deoxycytidine. Cells were
collected by re-addition of Thymidine, as outlined (Fig. 6a).
Immunofluorescence. Generally, S2 cells were settled for 20′ on polylysine coated
cells and fixed for 7′ with 3.7% formaldehyde solution (Sigma) in phosphate-
buffered saline (PBS) or in −20 °C methanol. For staining of endogenous Spt6 at
centromeres, shorter fixation conditions (3′ in PBS/0.1% Triton (PBS-T) contain-
ing 1.85% formaldehyde) were required. Following a wash in PBS-T, samples were
blocked with Image-iTTMFX signal enhancer (Invitrogen) for at least 30′. Samples
were stained at 4 °C overnight in PBS-T containing respective primary antibodies.
Unless otherwise noted, all antibodies were used 1:100 diluted: chicken α dCENP-A
(H31, 1:20; P. Heun, polyclonal), monoclonal rat α dCENP-A (4F8; E. Kremmer,
Helmholtz Zentrum München), rabbit α H3S10p (Abcam, ab5176, polyclonal),
mouse α GFP (Clone 496; D. van Essen, monoclonal), mouse α tubulin (Sigma,
T5168) and mouse α V5 (Invitrogen, Cat# R960-25, monoclonal). Monoclonal
antibodies were raised in the Helmholtz Zentrum München in rats or mice against
Spt6 amino acid residues 215–230 DYDDFSKYEEDDYEDD (mouse α dSpt6
(26D12, IgG2b, 1:50), rat α dSpt6 (13D4, IgG1; 1:50)). Secondary polyclonal goat
antibodies (Invitrogen) coupled to Alexa 488, Alexa 555 and Alexa 647 fluor-
ophores used (in the same order) were anti-rabbit (A-11070, A-21429, A-21246),
anti-mouse (A-11001, A-21422, A-21235), anti-chicken (A-11039, A-21437, A-
21449) and anti-rat for Alexa 488 (A-11006) were used at a 1:500 dilution and
incubated for 45′ at room temperature. Counterstaining of DNA was performed
with 4′,6-diamidino-2-phenylindole (DAPI) (5 µg/ml; 3′).
HeLa cells were fixed for 10′ at room temperature fixation in 500 µl of PBS/4%
formaldehyde solution. After aspiration, samples were quenched through addition
of 0.1 M Tris, pH 7.5 for 5′. Samples were permeabilized through a 5′ wash in PBS-
T and blocked for 30′ in PBS containing 2%FBS, 2% BSA, 0.1% Triton X-100 and
0.04% NaN3 At 37 °C. Antibody labeling was performed at 37 °C for 60′ (primary)
and 30′ (secondary) respectively. Antibodies against CENP-B (Santa Cruz
Biotechnology, sc-22788 Rabbit polyclonal) and cyclin B1 (sc-245; Santa Cruz
Biotechnology) were used at dilutions of 1:1000 and 1:50. Fluorescent secondary
antibodies Donkey anti-Rabbit FITC (Rockland, 611-702-127) and Donkey anti-
mouse 680 (Rockland, 610-744-124) were used at a dilution of 1:200.
Snap labeling. Stable SNAP-dCENP-A expressing S2 cells were labeled with TMR-
Star (New England Biolabs) at 3 µM final concentration for 30′, followed by three
washing steps with fresh culture medium for 10′ each. To assess steady-state levels,
cells were fixed as described below and subjected to IF or for pulse-chase labeling
with further incubation with 10 µM BTP (SNAP-Cell Block; New England Biolabs)
for 30′ and three washes with fresh culture medium. Cells were collected for mitotic
chromosome spread preparation (see below) at 0 h and 48 h after BTP blocking and
washing steps.
SNAP labeling in HeLa cells was performed for 15′ with 2 μM TMR-Star (New
England Biolabs) in complete medium for pulse labeling, after which cells were
washed twice with PBS and reincubated with complete medium. After an
additional 30′, cells were washed once more with PBS and reincubated with
complete medium with 2 μM BTP (SNAP-Cell Block; New England Biolabs) for 30′
and again washed with PBS and further treated for analysis, as indicated12 (Fig. 6a).
Mitotic chromosome spreads. A total of 0.2 × 105 cells were arrested for 30′ with
1 μg/ml colcemid. Supernatant after centrifugation (3′, 1000 g) was discarded, and
cells were resuspended in 500 μl of 0.5% (wt/vol) sodium citrate. After 10′ incu-
bation, each sample was transferred into a single-chamber cytospin tunnel and
spun on a polylysine- coated slide for 10′ at 91.45 g (900 rpm; high-acceleration) in
a Shandon Cytospin 4. After the spin, slides were immediately fixed in 3.7% for-
maldehyde solution (Sigma), then washed twice in PBS followed by two washes in
2× SSC buffer.
Click-it chemistry. S-phase cells were visualized using the Click-iT® EdU Imaging
Kit from Thermo Fisher Scientific following the manufacturer’s instructions
(labeling: 15′/10 µM EdU). Global RNA transcription was detected using the Click-
iT® RNA Imaging Kit from Thermo Fisher Scientific (labeling: 5′/4 mM EU). Cells
were pelleted and resuspended twice in 1 ml of medium to allow unbound EU to
diffuse (5′; 1000 g), before cells were settled and fixed as usual. Click-it reaction was
performed according to the manufacturer’s instruction.
Microscopy and image analysis. All images (see exception below) were taken on a
DeltaVision Elite Imaging System and were deconvolved using softWoRx Explorer
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Suite (Applied precision). Images of fixed cells were taken as 50–65z stacks of
0.2 µM increments using a 100× oil immersion objective. Time-lapse imaging was
performed with 25z stacks of 0.4 µM increments using a 60× oil immersion
objective and a time-lapse of 2′. Quantification of signal intensities was performed
using the softWoRx Explorer Suite. Average background of five non-centromeric
nuclear measurements was subtracted from measured centromeric signal (dCENP-
A, HA, V5 and MYC analysis) and average background of five cytoplasmic mea-
surements was subtracted from five measured nuclear signals (Spt6). Images of
SNAP-tagged dCENP-A expressing S2 cells were taken on a Leica TCS SP5
instrument. Image acquisition was performed using a 63× oil objective with a pixel
size of 48.1 nm and by collecting 0.13 µm z-sections spanning the entire nuclei. 3D
images were reconstructed and analyzed by Imaris v9.3. Centromeric TMR signals
were quantified by measuring the cumulative intensity of each spot. For better
comparability, all intensity signals were expressed as % relative to the 100% mean
of the 0 h time point in each cell line. To calculate the stability of the different
CENP-A mutant and wildt-ype proteins at the centromere over time, all values
were normalized to the respective 0 h samples. dCENP-A half-life and decay
constant k were calculated by determining average dCENP-A fluorescence inten-
sities at 0 and 48 h (two generations). A non-linear fit regression curve was pro-
duced using the one-phase-decay function in GraphPad Prism 8.4.0 based on
F= e−kt, where F is fluorescent signal intensity and t is number of divisions, with a
constrained F0= 100 and Plateau= 0. Half-life= ln(2)/k (Fig. 5g). HeLa cells were
imaged on a DeltaVision Core system (Applied Precision) and centromeres were
quantified with ImageJ with the CRaQ plugin12,58. For imaging a 60× oil objective
was used with NA 1.42, working distance 0.15.
Whole cell and nuclear extracts. All steps were carried out on ice/at 4 °C and all
used buffers contained in addition Protease inhibitor cocktail tablets (cOmplete
Tablets; Roche) and 0.5 mM PMSF. Cells were washed twice with PBS before lysis.
For whole cell extracts pelleted cells were resuspended in buffer L (50 mM Tris-
HCl, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1 mM MgCl2,) and sonicated
10× with an interval of 30″ on medium setting (Bioruptor300; Diagenode). Protein
concentrations were measured using Quick StartTM Bradford 1× Dye Reagent from
BIO RAD according to the manufacturers manual and equal amounts loaded for
each lane. For nuclear extracts, pelleted cells were incubated for 10′ in lysis buffer
(10 mM Hepes-KOH, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT). Nuclei were
pelleted and washed once with lysis buffer, resuspended in extraction buffer
(20 mM Hepes, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, and
0.5 mM DTT) plus Benzonase (Novagen; 100 U/ml) and incubated on ice for 20′.
Supernatant after centrifugation served as the nuclear extract.
Western blot analysis. Drosophila S2 cell samples were boiled for 10′ in loading
buffer separated on 6% (Spt6) or 10% (Co-IPs) SDS-PAGE gels and processed for
western blotting using mouse α GFP (1:2000, Clone 71; D. van Essen), monoclonal
mouse α Spt6 (25C6, Helmholtz Zentrum München, IgG2b 1:500) was raised
against Spt6 amino acid residues 215–230 DYDDFSKYEEDDYEDD, rabbit α
CENP-A (1:5000, ab10887, Abcam), mAB α Flag (Clone M2; 1:10000, F1804,
Sigma-Aldrich), rabbit α H3 (1:10000, ab1791, Abcam) and mouse α tubulin AA4.3
(1:1000; DSHB). Secondary polyclonal Goat antibodies (Sigma) coupled to
horseradish peroxidase Rabbit IgG HRP Linked Whole Ab, (NA934) and Mouse
IgG HRP Linked Whole Ab (GE Healthcare, NA931) were used at 1:10000. HeLa
cells were boiled in 2× Laemmli sample buffer and whole cell extracts were sepa-
rated by SDS-PAGE and transferred onto nitrocellulose membranes using a Trans
Blot System (BioRad). Antibodies used were SPT6 (Abcam, ab32820 rabbit poly-
clonal; 1:500), CENP-C (Gift from D. Cleveland UCSD, made in house from
Covance clone #3024, rabbit polyclonal; 1:10000) and α-tubulin (Sigma, T9026
mouse monoclonal; 1:1000). Secondary antibodies used were Donkey anti-Rabbit
800 (Li-Cor, 926–32211) and Donkey anti-mouse 680 (Rockland, 610-744-124;
both at 1:10000). Blots were visualized using Image Lab 6.1 (BIO RAD).
Co-immunoprecipitation. All steps were carried out on ice/at 4 °C, all used buffers
contained in addition protease inhibitor cocktail tablets (cOmplete Tablets; Roche)
and 0.5 mM PMSF. Mouse anti-Spt6 antibody (25C6, IgG2b) was coupled to
Protein A-Sepharose CL-4B (GE Healthcare) beads and stored at 4 °C until actual
pulldown. For nuclei purification, 50–100 × 106 cells were pelleted (10′; 1000 × g)
and resuspended in 5 ml of nuclear buffer A (85 mM KCL, 5.5% sucrose, 10 mM
Tris-HCl pH 7.5, 0.2 mM EDTA, 0.5 mM spermidine). Five mililiter of nuclear
buffer B (as A but containing 0.5% NP-40) was added and samples incubated for 3′
on ice. After centrifugation of nuclei (10′; 2000 × g), supernatant was discarded, the
pellet was washed twice with hypotonic buffer (20 mM HEPES-KOH pH7.9, 20
mM NaCl, 5 mM MgCl2, 10 mM imidazole and 0.5 mM β-mercaptoethanol) and
resuspended in 300 µl of hypotonic buffer containing 0.5% NP-40 (Sigma-Aldrich)
and 200 U Benzonase (Novagen) and incubated with rotation for 1 h. NaCl was
added to a final concentration of 300 mM and samples were rotated for 1 h before
salt concentration was brought to 150 mM through dilution with hypotonic buffer
containing 0.5% NP-40 (Sigma-Aldrich). Ten percent of the supernatant after
centrifugation (15′; 15000 × g) served as input and the remaining sample was either
split into two or three equal samples. Antibody-bound sepharose beads were added
to each sample and rotated overnight. Ten percent of the unbound supernatant
served as flowthrough and beads were washed for 1 h with hypotonic buffer
containing 0.5% NP-40 and either 150 mM or 750 mM NaCl (Fig. 4e). For Fig. 4d,
washes were performed with 150 mM salt buffer. Ten percent of each supernatant
served as the wash sample, beads were washed three additional times for 2′ with
buffer containing the respective salt concentration before bound proteins were
eluted by addition of 2× Laemmli sample buffer to obtain the IP sample.
Expression of recombinant proteins and pull-down assay. 6his-smt3-Spt6
(199–338) and 6his-smt3 were recombinantly expressed in bacteria. Histones H3,
H4, and CENP-A-ΔNT (101–225) were purified. Histones H3, H4, and CENP-A-
ΔNT (101–225) were expressed in Escherichia coli solubilized from inclusion
bodies and purified by sequential anion and cation exchange chromatography. H3/
H4 and CENP-A-ΔNT (101–225)/H4 histone tetramers were assembled by dialysis
into refolding buffer (10 mM Tris pH 8, 2 M NaCl, 1 mM EDTA, 5 mM ß-mer-
captoethanol) and purified by size exclusion chromatography on a Superdex 200
column71. 6his-smt3-Spt6 (199–338) and 6his-smt3 were incubated with dCENP-
AΔNT(101–225) or H3/H4 in Pull-Down Buffer containing 20 mM Tris-HCl pH 8,
0.5 mM β-Mercaptoethanol, 10 mM imidazole, 0.1% Triton X-100, 5% glycerol and
a final concentration of 250 mM NaCl on an overhead rotator for 1 h at 4 °C.
Afterward, input was taken and 20 µl HIS-Select® HF Nickel Affinity Gel (Sigma)
pre-equilibrated with Pull-Down Buffer was added to each sample and incubated
on an overhead rotator for 1 h at 4 °C. Beads were washed 5× with 1 ml Pull-Down
Buffer, bound proteins eluted with Laemmli Buffer at 95 °C for 5′ and analyzed on
15% SDS-PAGE gel stained with InstantBlue™ (Expedeon).
CRISPR/Cas9. Guide RNA sequences were selected using the flycrispr-tool http://
targetfinder.flycrispr.neuro.brown.edu/; Spt6-sgRNA5:TGACGACTTCTCAAAG-
TACGAGG; Spt6-sgRNA9: GGTTACGATTCCGATGGCGTCGG. Corresponding
forward and complementary reverse primers were hybridized and cloned into pAc-
sgRNA-Cas972, a gift from Ji-Long Liu (Addgene plasmid # 49330; http://n2t.net/
addgene:49330; RRID:Addgene_49330) using SapI creating pAc-Spt6-sgRNA5-
Cas9 and pAc-Spt6-sgRNA9-Cas9. The U6 sgRNA region containing sgRNA5 and
9 was amplified using dU6_2_sgRNA_F and dU6_2_3 sgRNA_R primers and the
PCR product was transfected into S2 cells along with a plasmid pIB_-
Cas9_CD4_Blast and the plasmid providing the GFP-tagged DNA repair template
(1kup_resGFPSpt6_stop). After 2 days, transfected cells were selected for 4 days
with blasticidin. GFP-positive cell clones were picked under the microscope and
amplified to produce clone C4 with all alleles tagged.
Flow cytometry cell cycle analysis. Cells were pelleted in a FACS tube (7′, 1000 ×
g) and fixed at 4 °C overnight in 70% ethanol. Fixed cells were stained for 1 h in the
dark (50 µg/ml propidium iodide, 100 µg/ml RNase in PBS) and directly subjected
to analysis on a BD FACScalibur Flow Cytometer using a gate for single cells with
BD FACSDiva 8.0.1 (gating strategy is provided as Supplementary Fig. 7) and
analyzed by FlowJo 10.1.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All relevant data supporting the findings of this study are available within the article and
its Supplementary Information files or from the corresponding author upon request. The
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